Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
Operating Expenses | 6,750 | 5,686 | 5,113 | 4,621 | 0 |
Operating Income | -6,750 | -5,686 | -5,113 | -4,621 | N/A |
Other Income | -3,532 | -5,062 | -1,215 | 831 | 0 |
Pre-tax Income | -10,282 | -10,748 | -6,328 | -3,790 | 0 |
Net Income Continuous | -10,282 | -10,748 | -6,328 | -3,790 | N/A |
Net Income | $-10,282 | $-10,748 | $-6,328 | $-3,790 | $N/A |
EPS Basic Total Ops | 15.09 | -10.81 | -6.59 | -4.07 | N/A |
EPS Basic Continuous Ops | 14.76 | -10.67 | -6.44 | -3.93 | N/A |
EPS Diluted Total Ops | 15.09 | -10.81 | -6.59 | -4.07 | N/A |
EPS Diluted Continuous Ops | 14.76 | -10.67 | -6.44 | -3.93 | N/A |
EBITDA(a) | $-5,903 | $-4,457 | $-4,165 | $-4,374 | $N/A |